Chamaida Plasencia

755 total citations
29 papers, 511 citations indexed

About

Chamaida Plasencia is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chamaida Plasencia has authored 29 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 11 papers in Immunology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chamaida Plasencia's work include Rheumatoid Arthritis Research and Therapies (18 papers), Spondyloarthritis Studies and Treatments (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Chamaida Plasencia is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Spondyloarthritis Studies and Treatments (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Chamaida Plasencia collaborates with scholars based in Spain, Netherlands and France. Chamaida Plasencia's co-authors include Alejandro Balsa, Alejandro Villalba, Laura Nuño, E. Martín‐Mola, Dora Pascual‐Salcedo, Gema Bonilla, María‐Eugenia Miranda‐Carús, Diana Peiteado, Ainhoa Ruiz del Agua and Jesús Díez‐Manglano and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

Chamaida Plasencia

29 papers receiving 499 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chamaida Plasencia 306 288 106 72 58 29 511
Alejandro Villalba 325 1.1× 387 1.3× 114 1.1× 65 0.9× 57 1.0× 27 635
I. Delaet 140 0.5× 363 1.3× 136 1.3× 173 2.4× 152 2.6× 16 515
Yasuhiro Tamimoto 233 0.8× 137 0.5× 76 0.7× 80 1.1× 31 0.5× 8 418
S Songcharoen 141 0.5× 421 1.5× 69 0.7× 184 2.6× 123 2.1× 7 654
M. Keiserman 225 0.7× 559 1.9× 137 1.3× 257 3.6× 171 2.9× 14 681
Uta Engling Poulsen 167 0.5× 514 1.8× 61 0.6× 172 2.4× 159 2.7× 5 603
Ayanbola Elegbe 116 0.4× 308 1.1× 59 0.6× 142 2.0× 104 1.8× 22 424
Juan Javier Lichauco 171 0.6× 284 1.0× 80 0.8× 43 0.6× 49 0.8× 12 397
E. C. Hsia 140 0.5× 481 1.7× 68 0.6× 265 3.7× 126 2.2× 34 546
Juan Antonio Martínez-López 100 0.3× 225 0.8× 16 0.2× 64 0.9× 83 1.4× 16 392

Countries citing papers authored by Chamaida Plasencia

Since Specialization
Citations

This map shows the geographic impact of Chamaida Plasencia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chamaida Plasencia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chamaida Plasencia more than expected).

Fields of papers citing papers by Chamaida Plasencia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chamaida Plasencia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chamaida Plasencia. The network helps show where Chamaida Plasencia may publish in the future.

Co-authorship network of co-authors of Chamaida Plasencia

This figure shows the co-authorship network connecting the top 25 collaborators of Chamaida Plasencia. A scholar is included among the top collaborators of Chamaida Plasencia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chamaida Plasencia. Chamaida Plasencia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novella-Navarro, Marta, Chamaida Plasencia, Victoria Navarro‐Compán, et al.. (2020). Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis. Arthritis Research & Therapy. 22(1). 284–284. 31 indexed citations
2.
Collada, J. Molina, Cristina Macía‐Villa, Chamaida Plasencia, José María Álvaro‐Gracia, & Eugenio de Miguel. (2020). Doppler enthesitis: a potential useful outcome in the assessment of axial spondyloarthritis and psoriatic arthritis. Clinical Rheumatology. 40(5). 2013–2020. 10 indexed citations
3.
Jiménez-Nàcher, Inmaculada, et al.. (2019). SAT0565 COST EVOLUTION OF BIOLOGICAL AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN A TERTIARY HOSPITAL INFLUENTIAL FACTORS IN PRICE. Annals of the Rheumatic Diseases. 78. 1375–1375. 1 indexed citations
4.
Villamañán, Elena, Inmaculada Jiménez-Nàcher, Francisco Moreno, et al.. (2019). Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price. Reumatología Clínica. 17(6). 335–342. 3 indexed citations
5.
Fernández-Fernández, Elisa, I. Monjo, Gema Bonilla, et al.. (2019). False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign. Lara D. Veeken. 59(9). 2443–2447. 42 indexed citations
6.
Martínez‐Feito, Ana, Chamaida Plasencia, Borja Hernández‐Breijo, et al.. (2019). FRI0399 INFLIXIMAB TROUGH LEVELS AND DISEASE ACTIVITY PREDICT EARLY CLINICAL RESPONSE IN PATIENTS WITH AXIAL SPONDYLOARHTRITIS. Annals of the Rheumatic Diseases. 78. 885–885. 1 indexed citations
7.
Fernández-Fernández, Elisa, I. Monjo, Chamaida Plasencia, et al.. (2019). OP0210 FALSE POSITIVES OF ULTRASOUND IN GIANT CELL ARTERITIS. SOME DISEASES CAN ALSO HAVE HALO SIGN. Annals of the Rheumatic Diseases. 78. 181–181. 6 indexed citations
8.
Villamañán, Elena, Inmaculada Jiménez-Nàcher, Francisco Moreno, et al.. (2018). Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price. International Journal of Clinical Pharmacy. 40(6). 1528–1538. 6 indexed citations
9.
Schie, Karin A. van, Pleuni Ooijevaar‐de Heer, Simone Kruithof, et al.. (2017). Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies. Annals of the Rheumatic Diseases. 76(7). 1285–1288. 14 indexed citations
10.
Plasencia, Chamaida, et al.. (2017). Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis. Therapeutic Drug Monitoring. 39(4). 364–369. 20 indexed citations
11.
Castillo-Gallego, C., Eugenio de Miguel, Miriam García‐Arias, et al.. (2017). Color Doppler and spectral Doppler ultrasound detection of active sacroiliitis in spondyloarthritis compared to physical examination as gold standard. Rheumatology International. 37(12). 2043–2047. 6 indexed citations
12.
Ruiz-Argüello, M. Begoña, Ainhoa Ruiz del Agua, Dora Pascual‐Salcedo, et al.. (2016). Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars. Annals of the Rheumatic Diseases. 75(9). 1693–1696. 57 indexed citations
13.
Moreno-Ramos, Francisco, et al.. (2015). Anti-tnf dose and anti-drug antibody levels in rheumatic and psoriasis patients: Economic repercussion. 17(2). 4. 3 indexed citations
14.
Plasencia, Chamaida, Teresa Jurado‐Guerrero, Alejandro Villalba, et al.. (2015). Effect of Infliximab Dose Increase in Rheumatoid Arthritis at Different Trough Concentrations: A Cohort Study in Clinical Practice Conditions. Frontiers in Medicine. 2. 71–71. 8 indexed citations
15.
Plasencia, Chamaida, E. Kneepkens, Gertjan Wolbink, et al.. (2015). Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity. The Journal of Rheumatology. 42(9). 1638–1646. 29 indexed citations
16.
Mola, Emilio Martín, Alejandro Balsa, V. Martínez Taboada, et al.. (2014). Documento práctico para el uso de abatacept subcutáneo. Reumatología Clínica. 10(4). 218–226. 2 indexed citations
17.
Mola, Emilio Martín, Alejandro Balsa, V. Martínez Taboada, et al.. (2014). Practice Guidelines for the Use of Subcutaneous Abatacept. Reumatología Clínica (English Edition). 10(4). 218–226. 2 indexed citations
18.
Balsa, Alejandro, P. Aguado, Chamaida Plasencia, et al.. (2014). Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis. Arthritis Research & Therapy. 16(6). 500–500. 79 indexed citations
19.
Mola, Emilio Martín, Alejandro Balsa, V. Martínez Taboada, et al.. (2013). El uso de abatacept en artritis reumatoide: revisión de la evidencia y recomendaciones. Reumatología Clínica. 9(1). 5–17. 13 indexed citations
20.
Plasencia, Chamaida, Dora Pascual‐Salcedo, Laura Nuño, et al.. (2012). Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab. Annals of the Rheumatic Diseases. 71(12). 1955–1960. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro Villalba Breakdown of academic impact, for papers by I. Delaet Breakdown of academic impact, for papers by Yasuhiro Tamimoto Breakdown of academic impact, for papers by S Songcharoen Breakdown of academic impact, for papers by M. Keiserman Breakdown of academic impact, for papers by Uta Engling Poulsen Breakdown of academic impact, for papers by Ayanbola Elegbe Breakdown of academic impact, for papers by Juan Javier Lichauco Breakdown of academic impact, for papers by E. C. Hsia Breakdown of academic impact, for papers by Juan Antonio Martínez-López
Rankless by CCL
2026